Skip to main content
Livermore
Livermore
ZHEN

Advisor Group Holdings, Inc.

SEC CIK
0001677044
Latest filing
Aug 14, 2026

AVDL holding history

Avadel Pharmaceuticals PLC in every 13F filed by Advisor Group Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVDL overviewAll 13F holders of AVDLFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of AVDL by Advisor Group Holdings, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−16,829−100.0%Sold outHolders
Q4 202516,829$362.7K<0.1%−31,685−65.3%ReducedHolders
Q3 202548,514$716.9K<0.1%−523−1.1%ReducedHolders
Q2 202549,037$434.0K<0.1%−509−1.0%ReducedHolders
Q1 202549,546$387.9K<0.1%−2,825−5.4%ReducedHolders
Q4 202452,371$550.4K<0.1%+34,819+198.4%AddedHolders
Q3 202417,552$230.3K<0.1%+15,520+763.8%AddedHolders
Q2 20242,032$28.6K<0.1%−3,226−61.4%ReducedHolders
Q1 20245,258$88.8K<0.1%−1,161−18.1%ReducedHolders
Q4 20236,419$90.6K<0.1%−14,178−68.8%ReducedHolders
Q3 202320,597$212.1K<0.1%+957+4.9%AddedHolders
Q2 202319,640$323.7K<0.1%+2,439+14.2%AddedHolders
Q1 202317,201$157.6K<0.1%−600−3.4%ReducedHolders
Q4 202217,801$127.6K<0.1%+1,700+10.6%AddedHolders
Q3 202216,101$81.0K<0.1%+13,975+657.3%AddedHolders
Q2 20222,126$5.00K<0.1%00.0%UnchangedHolders
Q1 20222,126$15.0K<0.1%−63−2.9%ReducedHolders
Q4 20212,189$18.0K<0.1%+23+1.1%AddedHolders
Q3 20212,166$21.0K<0.1%−8,047−78.8%ReducedHolders
Q2 202110,213$69.0K<0.1%−1,000−8.9%ReducedHolders
Q1 202111,213$101.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.